START FREE TRIAL

Warren Buffett’s Quiet Bet On The New York Times—Signal Or Sideshow?

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

When Warren Buffett’s Berkshire Hathaway disclosed a new 5-million-share stake in The New York Times Company (NYSE:NYT), it didn’t exactly shake Wall Street. At roughly $350–$375 million, it’s tiny by Berkshire standards—especially compared with its still-massive Apple and American Express holdings. But the context matters. Berkshire was a net seller in the fourth quarter, trimming Apple, cutting Bank of America again, and slashing Amazon by nearly 80%. Against that backdrop, initiating a new position—however small—looks deliberate. The New York Times just posted 1.4 million net new digital subscribers in 2025, crossed $2 billion in digital revenue for the first time, expanded margins to 19.5%, and generated over $550 million in free cash flow. This isn’t a nostalgic newspaper trade. It’s a bet on a scaled digital subscription platform with advertising leverage and pricing power. The question isn’t whether Buffett loves newspapers. It’s whether this modern Times fits Berkshire’s playbook in a selective, valuation-aware way.

Digital Subscription Flywheel

The New York Times’ core engine is no longer print. It’s a digital subscription flywheel that now stands at12.8 million total subscribers after adding 1.4 million net new digital subscribers in 2025. That scale matters. Digital-only subscription revenue grew…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

This Biotech Stock Already Has A Blockbuster; So Why Is It ACQUIRING Another Rare Disease Asset?

There are biotech stories that look obvious, and then...

This AI Infra Stock Could Anchor 6G And Edge Computing; PE Knows It’s MISPRICED!

There’s a reason SBA Communications (NASDAQ: SBAC) has suddenly...

Unilever’s $42 Billion Selloff Is Hiding a Much BIGGER Bet!

Unilever (NYSE: UL) did not just announce a deal—it...

Nike’s China Slump Is Starting to Look Like Something More!

Nike (NYSE:NKE) has spent years selling the idea that...

This “Broken” Biotech Just Forced Wall Street To Blink

Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle...

Related Articles

This AI Infra Stock Could Anchor 6G And Edge Computing; PE Knows It’s MISPRICED!

There’s a reason SBA Communications (NASDAQ: SBAC) has suddenly...

Unilever’s $42 Billion Selloff Is Hiding a Much BIGGER Bet!

Unilever (NYSE: UL) did not just announce a deal—it...

Nike’s China Slump Is Starting to Look Like Something More!

Nike (NYSE:NKE) has spent years selling the idea that...

This “Broken” Biotech Just Forced Wall Street To Blink

Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle...

Tesla Is Quietly Killing Its Own Cars—& What Comes Next Could Be MUCH BIGGER

For years, most investors have approached Tesla as an...

This Medical Device Stock Just Got CRUSHED On One Hidden Number; Did Wall Street Misread It?

Boston Scientific (NYSE:BSX) spent the weekend putting forward what...

This Widely Held “Defensive” Stock Is Now Tied To A Large Scale Merger

For years, McCormick (NYSE:MKC) has been framed as one...
spot_img

Related Articles

Popular Categories

spot_imgspot_img